BMY Pummeled After Earnings, But Bristol-Myers Squibb Stock Still a Buy By: InvestorPlace January 24, 2014 at 11:20 AM EST Read More >> Related Stocks: Astrazeneca Plc ADR Bristol-Myers Squibb Gilead Sciences